Aspirin use may change cost-effectiveness of COX-2 inhibitors.
Pickard
A Simon
AS
Schumock
Glen T
GT
D001241:Aspirin / Q000008:administration & dosage* / Q000191:economics*; D015331:Cohort Studies; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage* / Q000191:economics*; D005260:Female; D006801:Humans; D008297:Male; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D016861:Cyclooxygenase Inhibitors; D001241:Aspirin